Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
Go back to Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data| (NASDAQ: RXRX) | Delayed: 3.28 -0.07 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.35 | 52 Week High | $ | |||
| Open | $3.37 | 52 Week Low | $ | |||
| Day High | $3.38 | P/E | N/A | |||
| Day Low | $3.26 | EPS | $ | |||
| Volume | 6,527,165 | |||||

